Digital Health Apps Have Underperformed, But VR Is ‘Very Different’ – Cedars-Sinai Virtual Medicine

Virtual Reality Therapy Is Drawing Strong Pharma Attention, Says Director Brennan Spiegel

Cedars-Sinai’s Virtual Medicine director Brennan Spiegel discusses the shortage of mental health professional resources and how Medical Extended Reality – e.g., immersing patients in a virtual world with an AI therapy avatar – is helping to address depression, pain, and a growing host of health and wellness needs in hospital and consumer settings.

• Source: Shutterstock

[Editor's note: A version of this story appeared first in our sister publication, Medtech Insight.]

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Digital Technologies

More from HBW Insight

US FDA Staff’s Union President Calls For More Support From Industry

 

Industry should be more vocal about the harms the recent reduction-in-force will have on getting drugs to market, NTEU Chapter 282 President Anthony Lee said in an interview with Pink Sheet.

FDA Reorganization Proposal A ‘Mindless Approach To Centralization,’ Woodcock Says

 
• By 

Plan to reorganize the agency into five offices was designed by someone who does not understand the FDA, former long-time agency official Janet Woodcock says. The proposal would eliminate highly specialized expertise in favor of “a big team of generalists,” former Principal Deputy Commissioner Joshua Sharfstein says.

Futura Records First Profits And Targets Eroxon Extension

 
• By 

The US launch of Eroxon ED treatment by Haleon helped Futura Medical record its first ever profit in 2024. The UK firm will now look to capitalize this by seeking US and EU approval for a more potent Eroxon line extension.